Literature DB >> 19167797

The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) Trial.

David R Jacobs1, Myron D Gross, Lyn Steffen, Michael W Steffes, Xinhua Yu, Laura P Svetkey, Lawrence J Appel, William M Vollmer, George A Bray, Thomas Moore, Paul R Conlin, Frank Sacks.   

Abstract

BACKGROUND: Dietary studies designed to decrease the urinary albumin excretion rate (AER) typically reduce protein by increasing lower protein plant foods and decreasing higher protein animal products. STUDY
DESIGN: We evaluated AER while increasing protein intake in the Dietary Approaches to Stop Hypertension (DASH) Trial (randomized, parallel group, 8 week controlled feeding). SETTING & PARTICIPANTS: 378 individuals without diabetes with prehypertension or stage I hypertension. INTERVENTION: The DASH diet, 18% energy from protein, emphasizes, among other features, low-fat dairy products; and the fruit/vegetable (FV) and control diets, each with 15% energy from protein. OUTCOME: AER. MEASUREMENTS: We measured AER by using immunoassay and covariates at baseline and after 8 weeks.
RESULTS: Baseline AER had a geometric mean value of 4.0 +/- 0.2 (SE) mg/24 h. In 285 participants with baseline AER less than 7 mg/24 h, AER was unchanged by diet treatment (geometric mean, 2.5 +/- 0.2 mg/24 h in the control diet, 3.0 +/- 0.2 mg/24 h in the FV diet, and 2.8 +/- 0.2 mg/24 h in the DASH diet). Conversely, in 93 participants with baseline AER of 7 mg/24 h or greater, end-of-feeding AER was lower in the FV diet (6.6 +/- 1.0 mg/24 h) than in the control (11.4 +/- 1.8 mg/24 h; P = 0.01) or DASH diets (11.7 +/- 1.6 mg/24 h; P = 0.005). The DASH and control diets were not different (P = 0.9). LIMITATIONS: Long-term AER change not studied.
CONCLUSIONS: The decrease in AER after 8 weeks occurred in only those with high-normal baseline AER in the FV diet, in a pattern distinct from the blood pressure decrease. The DASH diet did not increase AER despite a 3% increase in energy from protein.

Entities:  

Mesh:

Year:  2009        PMID: 19167797      PMCID: PMC2676223          DOI: 10.1053/j.ajkd.2008.10.048

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  32 in total

1.  Animal versus plant protein meals in individuals with type 2 diabetes and microalbuminuria: effects on renal, glycemic, and lipid parameters.

Authors:  Madelyn L Wheeler; S Edwin Fineberg; Naomi S Fineberg; Reid G Gibson; Laurie L Hackward
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

2.  [Weight reduction improves high blood pressure and microalbuminuria in hypertensive patients with obesity].

Authors:  H Ohashi; H Oda; M Ohno; S Watanabe
Journal:  Nihon Jinzo Gakkai Shi       Date:  2001-05

3.  Recruitment and baseline characteristics of participants in the Dietary Approaches to Stop Hypertension trial. DASH Collaborative Research Group.

Authors:  L J Appel; W M Vollmer; E Obarzanek; K M Aicher; P R Conlin; B M Kennedy; J B Charleston; P M Reams
Journal:  J Am Diet Assoc       Date:  1999-08

4.  Descriptive characteristics of the dietary patterns used in the Dietary Approaches to Stop Hypertension Trial. DASH Collaborative Research Group.

Authors:  N M Karanja; E Obarzanek; P H Lin; M L McCullough; K M Phillips; J F Swain; C M Champagne; K P Hoben
Journal:  J Am Diet Assoc       Date:  1999-08

5.  Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.

Authors:  Johan Arnlöv; Jane C Evans; James B Meigs; Thomas J Wang; Caroline S Fox; Daniel Levy; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-08-08       Impact factor: 29.690

6.  Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial.

Authors:  Jorge L Gross; Themis Zelmanovitz; Cileide C Moulin; Vanessa De Mello; Magda Perassolo; Cristiane Leitão; Alice Hoefel; Alexandre Paggi; Mirela J Azevedo
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

7.  Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects.

Authors:  A R Skov; S Toubro; J Bülow; K Krabbe; H H Parving; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  1999-11

8.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 9.  Dietary protein restriction benefits patients with chronic kidney disease.

Authors:  Sreedhar Mandayam; William E Mitch
Journal:  Nephrology (Carlton)       Date:  2006-02       Impact factor: 2.506

10.  Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study.

Authors:  David R Jacobs; Maureen A Murtaugh; Michael Steffes; Xinhua Yu; Jeffrey Roseman; Frederick C Goetz
Journal:  Am J Epidemiol       Date:  2002-06-15       Impact factor: 4.897

View more
  18 in total

Review 1.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

2.  Plant-Based Diets and Incident CKD and Kidney Function.

Authors:  Hyunju Kim; Laura E Caulfield; Vanessa Garcia-Larsen; Lyn M Steffen; Morgan E Grams; Josef Coresh; Casey M Rebholz
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-25       Impact factor: 8.237

3.  Urinary Potassium Excretion and Progression of CKD.

Authors:  Hyung Woo Kim; Jung Tak Park; Tae-Hyun Yoo; Joongyub Lee; Wookyung Chung; Kyu-Beck Lee; Dong-Wan Chae; Curie Ahn; Shin-Wook Kang; Kyu Hun Choi; Seung Hyeok Han
Journal:  Clin J Am Soc Nephrol       Date:  2019-02-14       Impact factor: 8.237

Review 4.  The Western Diet and Chronic Kidney Disease.

Authors:  Divya Hariharan; Kavitha Vellanki; Holly Kramer
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

5.  DASH dietary pattern and chronic kidney disease in elderly Korean adults.

Authors:  H S Lee; K B Lee; Y Y Hyun; Y Chang; S Ryu; Y Choi
Journal:  Eur J Clin Nutr       Date:  2016-12-14       Impact factor: 4.016

Review 6.  What an anticardiovascular diet should be in 2015.

Authors:  David R Jacobs; Linda C Tapsell
Journal:  Curr Opin Lipidol       Date:  2015-08       Impact factor: 4.776

Review 7.  KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline.

Authors:  Holly J Kramer; Raymond R Townsend; Karen Griffin; Joseph T Flynn; Daniel E Weiner; Michael V Rocco; Michael J Choi; Matthew R Weir; Tara I Chang; Rajiv Agarwal; Srinivasan Beddhu
Journal:  Am J Kidney Dis       Date:  2019-04       Impact factor: 8.860

8.  Lifestyle-related factors, obesity, and incident microalbuminuria: the CARDIA (Coronary Artery Risk Development in Young Adults) study.

Authors:  Alex Chang; Linda Van Horn; David R Jacobs; Kiang Liu; Paul Muntner; Britt Newsome; David A Shoham; Ramon Durazo-Arvizu; Kirsten Bibbins-Domingo; Jared Reis; Holly Kramer
Journal:  Am J Kidney Dis       Date:  2013-04-17       Impact factor: 8.860

9.  Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study.

Authors:  Alex Chang; Bryan C Batch; Heather L McGuire; William M Vollmer; Laura P Svetkey; Crystal C Tyson; Anawin Sanguankeo; Cheryl Anderson; Jessica Houston; Lawrence J Appel
Journal:  Am J Kidney Dis       Date:  2013-06-28       Impact factor: 8.860

Review 10.  Healthy Dietary Patterns and Risk of Mortality and ESRD in CKD: A Meta-Analysis of Cohort Studies.

Authors:  Jaimon T Kelly; Suetonia C Palmer; Shu Ning Wai; Marinella Ruospo; Juan-Jesus Carrero; Katrina L Campbell; Giovanni F M Strippoli
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-08       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.